Reporting ChinaAMC Hang Seng Hong Kong Biotech Index ETF
Share
IFRS
Annual
Quarterly
| 2013 | 2014 | 2015 | 2016 | 2021 | 2022 | 2023 | 2024 | 2025 | LTM | 5 year average | CAGR 5 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Цена акции ао | 8.84 | 10.3 | 7.68 | 8.83 | 16.56 | 13.41 | 10.32 | 8.69 | 11.58 | 11.58 | 12.11 | -6.90 |
Efficiency
IFRS
Annual
| 2023 | 2024 | 2025 | LTM | Industry average | 5 year average | CAGR 5 | |
|---|---|---|---|---|---|---|---|
| ROS, % | 0 | 0 | 0 | 0 | |||
| ROCE, % | 0 | 0 | |||||
| Ebit margin, % | 0 | 0 | |||||
| Рентаб EBITDA, % | 0 | 0 | |||||
| Operation Margin, % | 0 | 0 | 0 | 0 |
Coefficients
IFRS
Annual
Quarterly
Dividends
IFRS
Annual
Quarterly
| 2022 | 2023 | 2024 | LTM | Industry average | 5 year average | CAGR 5 | |
|---|---|---|---|---|---|---|---|
|
Дивиденд
|
0.0051 | 0.0039 | 0.0077 | 0.0077 | 0.0056 | 14.72 | |
|
Див доход, ао, %
|
0.2983 | 0.3604 | 0.3326 | 0.3326 | 0.3304 | 3.69 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
